EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $678,000 | +2612.0% | 461,240 | +2062.5% | 0.00% | – |
| Q1 2022 | $25,000 | -64.8% | 21,329 | -24.5% | 0.00% | – |
| Q4 2021 | $71,000 | -94.0% | 28,258 | -87.8% | 0.00% | -100.0% |
| Q3 2021 | $1,182,000 | -65.7% | 230,887 | -44.4% | 0.00% | -50.0% |
| Q2 2021 | $3,448,000 | +15.9% | 414,904 | +21.4% | 0.00% | 0.0% |
| Q1 2021 | $2,976,000 | +446.1% | 341,693 | +580.9% | 0.00% | – |
| Q4 2020 | $545,000 | +57.5% | 50,179 | +73.0% | 0.00% | – |
| Q3 2020 | $346,000 | -81.5% | 29,004 | -75.1% | 0.00% | -100.0% |
| Q2 2020 | $1,871,000 | +133.0% | 116,548 | +125.1% | 0.00% | 0.0% |
| Q1 2020 | $803,000 | +19.9% | 51,784 | +90.1% | 0.00% | – |
| Q4 2019 | $670,000 | -23.8% | 27,243 | -68.0% | 0.00% | -100.0% |
| Q3 2019 | $879,000 | +2.4% | 85,177 | +24.5% | 0.00% | 0.0% |
| Q2 2019 | $858,000 | +291.8% | 68,416 | +285.7% | 0.00% | – |
| Q1 2019 | $219,000 | -78.4% | 17,736 | -89.2% | 0.00% | -100.0% |
| Q4 2018 | $1,013,000 | +145.9% | 164,470 | +324.0% | 0.00% | – |
| Q3 2018 | $412,000 | +622.8% | 38,789 | +819.2% | 0.00% | – |
| Q2 2018 | $57,000 | -76.3% | 4,220 | -68.9% | 0.00% | – |
| Q1 2018 | $241,000 | -72.1% | 13,581 | -80.3% | 0.00% | -100.0% |
| Q4 2017 | $864,000 | +24.7% | 68,904 | +89.2% | 0.00% | 0.0% |
| Q3 2017 | $693,000 | +35.4% | 36,411 | +7.6% | 0.00% | – |
| Q2 2017 | $512,000 | +316.3% | 33,843 | +373.1% | 0.00% | – |
| Q1 2017 | $123,000 | -76.9% | 7,154 | -83.7% | 0.00% | – |
| Q4 2016 | $533,000 | +620.3% | 44,013 | +481.4% | 0.00% | – |
| Q3 2016 | $74,000 | -24.5% | 7,570 | -20.7% | 0.00% | – |
| Q2 2016 | $98,000 | -76.9% | 9,545 | -72.7% | 0.00% | – |
| Q1 2016 | $424,000 | +443.6% | 35,003 | +616.8% | 0.00% | – |
| Q4 2015 | $78,000 | -80.4% | 4,883 | -84.3% | 0.00% | – |
| Q3 2015 | $398,000 | +34.5% | 31,025 | +151.7% | 0.00% | – |
| Q2 2015 | $296,000 | +35.2% | 12,326 | +5.5% | 0.00% | – |
| Q1 2015 | $219,000 | -14.5% | 11,688 | -14.1% | 0.00% | – |
| Q4 2014 | $256,000 | +89.6% | 13,599 | +174.9% | 0.00% | – |
| Q3 2014 | $135,000 | -93.5% | 4,946 | -92.6% | 0.00% | -100.0% |
| Q2 2014 | $2,078,000 | -80.4% | 66,787 | -85.7% | 0.00% | -81.8% |
| Q1 2014 | $10,627,000 | +9649.5% | 466,721 | +8822.2% | 0.01% | – |
| Q4 2013 | $109,000 | – | 5,231 | +52210.0% | 0.00% | – |
| Q3 2013 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |